Abstract:Epidermal keratinocytes synthesize and secrete α‐melanocyte stimulating hormone (α‐MSH) and adrenocorticotropic hormone (ACTH). These act as agonists of the melanocortin 1 receptor expressed on the cell surface of human melanocytes. Binding of these physiological agonists or synthetic α‐MSH analogs to human MC1R activates the cAMP pathway, leading to activation of transcription factors, mainly p53, MITF, and Nrf2. The downstream targets of these transcription factors enhance DNA repair and antioxidant capacities, promote melanocyte survival, and increase eumelanin synthesis. These pleotropic effects confer photoprotection and prevent vitiligo. The physiological role of α‐melanocyte stimulating hormone in regulating integumental pigmentation of many vertebrate species has been recognized since the 1960's. However, its physiological significance for human pigmentation remained enigmatic until the 1990's. α‐Melanocyte stimulating hormone and related melanocortins are synthesized locally in the skin, primarily by keratinocytes, in addition to the pituitary gland, and therefore act as paracrine factors for melanocytes. Human melanocytes express the melanocortin 1 receptor, which recognizes α‐melanocyte stimulating hormone and the related adrenocorticotropic hormone as agonists. This review summarizes the current knowledge of the pleotropic effects of the activated melanocortin 1 receptor that maintain human melanocyte homeostasis by regulating melanogenesis and the response to environmental stressors, mainly solar radiation. Certain allelic variants of the melanocortin 1 receptor gene are associated with specific pigmentary phenotypes in various human populations. Variants associated with red hair phenotype compromise the function of the encoded receptor. Activation of the human melanocortin 1 receptor regulates eumelanin synthesis and enhances DNA damage response of melanocytes to solar radiation and oxidative stressors. We describe how synthetic selective melanocortin 1 receptor agonists can be efficacious as sunless tanning agents, for treatment of vitiligo and photosensitivity disorders, and for prevention of skin cancer, including melanoma.

Human Melanocyte Biology, Toxicology, and Pathology

Melanocyte lineage dynamics in development, growth and disease

Melanocyte biology and skin pigmentation

Melanocytes in regenerative medicine applications and disease modeling

Biology of melanocytes in mammals

Journey through the spectacular landscape of melanocortin 1 receptor

Human melanocyte development and melanoma dedifferentiation at single-cell resolution

Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis

Melanocyte stem cells as potential therapeutics in skin disorders

Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders

The melanocyte lineage in development and disease

Solar exposure, the melanocyte and melanoma: Survival pathways and molecular mechanisms.

Melanin transfer and fate within keratinocytes in human skin pigmentation.

Disorders of Melanin Pigmentation

Signaling Pathways in Melanogenesis

Recognition of Melanocytes in Immuno-Neuroendocrinology and Circadian Rhythms: Beyond the Conventional Melanin Synthesis

The cell biology of human hair follicle pigmentation

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

The Immune Characteristics of Melanocytes and Their Relationship with Ultraviolet Irradiatio

Regulation of melanocyte stem cells in the pigmentation of skin and its appendages: Biological patterning and therapeutic potentials

Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis